AI Article Synopsis

  • - The study aimed to explore the relationship between different sources of dietary protein, amino acid intake, and the risk of prostate cancer among 131,425 men over an average follow-up of 14.2 years.
  • - Results indicated that higher dairy protein and yogurt protein intakes were associated with a slightly increased risk of prostate cancer, while no strong associations were found for egg protein or different tumor subtypes.
  • - Overall, the findings suggest only weak positive associations between protein intakes and prostate cancer risk that require further confirmation through larger studies.

Article Abstract

Background: The association between protein intake and prostate cancer risk remains unclear.

Aims: To prospectively investigate the associations of dietary intakes of total protein, protein from different dietary sources, and amino acids with prostate cancer risk and mortality.

Methods: In 131,425 men from the European Prospective Investigation into Cancer and Nutrition, protein and amino acid intakes were estimated using validated dietary questionnaires. Multivariable-adjusted Cox regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).

Results: During a mean follow-up of 14.2 years, 6939 men were diagnosed with prostate cancer and 914 died of the disease. Dairy protein was positively associated with overall prostate cancer risk in the three highest fifths compared to the lowest (HR =1.14 (95% CI 1.05-1.23); HR 4=1.09 (1.01-1.18); HR =1.10 (1.02-1.19)); similar results were observed for yogurt protein (HR =1.14 (1.05-1.24); HR =1.09 (1.01-1.18); HR =1.12 (1.04-1.21)). For egg protein intake and prostate cancer mortality, no association was observed by fifths, but there was suggestive evidence of a positive association in the analysis per standard deviation increment. There was no strong evidence of associations with different tumour subtypes.

Discussion: Considering the weak associations and many tests, the results must be interpreted with caution.

Conclusion: This study does not provide strong evidence for an association of intakes of total protein, protein from different dietary sources or amino acids with prostate cancer risk or mortality. However, our results may suggest some weak positive associations, which need to be confirmed in large-scale, pooled analyses of prospective data.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972153PMC
http://dx.doi.org/10.1002/cam4.5289DOI Listing

Publication Analysis

Top Keywords

prostate cancer
28
cancer risk
20
protein
10
cancer
9
protein amino
8
amino acid
8
acid intakes
8
european prospective
8
prospective investigation
8
investigation cancer
8

Similar Publications

Objective: The objective of this study is to analyse the perspectives of screening candidates and healthcare professionals on shared decision-making (SDM) in prostate cancer (PCa) screening using the prostate-specific antigen (PSA) test.

Design: Descriptive qualitative study (May-December 2022): six face-to-face focus groups and four semistructured interviews were conducted, transcribed verbatim and thematically analysed using ATLAS.ti software.

View Article and Find Full Text PDF

Thiamine Deficiency Is Common and Underrecognized in Emergency Department Oncology Patients.

J Clin Med

January 2025

Department of Emergency Medicine, Henry Ford Health, Detroit, MI 48202, USA.

: Wernicke's encephalopathy can occur in oncology patients independent of alcohol use, likely resulting from poor dietary thiamine intake. High metabolic demands, such as those in acute illnesses seen in the emergency department (ED), can exacerbate thiamine deficiency. In this study, our objective was to assess the incidence of thiamine deficiency in ED oncology patients, which could lead to Wernicke's encephalopathy or other thiamine deficiency disorders if left untreated.

View Article and Find Full Text PDF

Prostate cancer (PCa) is prevalent among men over 70. Treatment may involve interventions like radical prostatectomy. The objective of this study was to investigate the combination of adverse pathology patterns on PCa progression through the Briganti 2012 nomogram and EAU risk classes in elderly patients treated with robotic surgery.

View Article and Find Full Text PDF

To establish a machine learning (ML) model for predicting prostate biopsy outcomes using prostate-specific antigen (PSA) values, multiparametric magnetic resonance imaging (mpMRI) findings, and hematologic parameters. The medical records of the patients who had undergone a prostate biopsy were evaluated. Laboratory findings, mpMRI findings, and prostate biopsy results were collected.

View Article and Find Full Text PDF

Oligometastatic prostate cancer (OMPC) represents an intermediate state in the progression from localized disease to widespread metastasis when the radiographically significant sites are limited in number and location. With no clear consensus on a definition, its diagnostic significance and associated optimal therapeutic approach remain controversial, posing a significant challenge for clinicians. The current standard of care for metastatic disease is to start systemic therapy; however, active surveillance and targeted radiotherapy have become attractive options to mitigate the long-term effects of androgen deprivation therapy (ADT).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!